Concepedia

Author

Jurjan Aman

Amsterdam University Medical CentersORCID

Also Known As

Aman, J., Aman, Jurjan, Esther J. Nossent, Esther Nossent, H Edenwall, Harbaum, Lars, Harm Jan Bogaard, J Aman, J. Aman, Jemal Aman

151

Publications

2.5K

Citations

27

H-Index

43

Concepts

All Affiliations

Amsterdam University Medical CentersAmsterdam UMC Location Vrije Universiteit AmsterdamUniversity of AmsterdamVrije Universiteit AmsterdamErasmus MC
JA

About

Jurjan Aman is an author at Amsterdam University Medical Centers specializing in medicine, immunology, and vascular biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

449

2

Health Sciences

2

2

47

3

Cell Biology

2

2

54

4

Cellular Physiology

1

1

41

5

Diabetes

1

1

27

Jurjan Aman

×

27

Publications

1.4K

Citations

20

H-Index

YearCitations

High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote inflammation by alveolar macrophages

Willianne Hoepel, Hung‐Jen Chen, Chiara E. Geyer,

Science Translational Medicine

2021

245

Effective Treatment of Edema and Endothelial Barrier Dysfunction With Imatinib

Jurjan Aman, Jan van Bezu, Amin Damanafshan,

Circulation

2012

178

Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial

Jurjan Aman, Erik Duijvelaar, Liza Botros,

The Lancet Respiratory Medicine

2021

122

Plasma protein levels are markers of pulmonary vascular permeability and degree of lung injury in critically ill patients with or at risk for acute lung injury/acute respiratory distress syndrome*

Jurjan Aman, M. van der Heijden, Arthur van Lingen,

Critical Care Medicine

2010

84

Dasatinib increases endothelial permeability leading to pleural effusion

Carole Phan, Étienne-Marie Jutant, Ly Tu,

European Respiratory Journal

2018

74

The BCR-ABL1 Inhibitors Imatinib and Ponatinib Decrease Plasma Cholesterol and Atherosclerosis, and Nilotinib and Ponatinib Activate Coagulation in a Translational Mouse Model

Marianne Pouwer, Elsbet Pieterman, Lars Verschuren,

Frontiers in Cardiovascular Medicine

2018

64

Anti-SARS-CoV-2 IgG from severely ill COVID-19 patients promotes macrophage hyper-inflammatory responses

Willianne Hoepel, Hung‐Jen Chen, Sona Allahverdiyeva,

2020

64

Predictors of pulmonary edema formation during fluid loading in the critically ill with presumed hypovolemia*

Jurjan Aman, A. B. Johan Groeneveld, Geerten P. van Nieuw Amerongen

Critical Care Medicine

2011

62

Dissecting the Effects of Ischemia and Reperfusion on the Coronary Microcirculation in a Rat Model of Acute Myocardial Infarction

Maurits R. Hollander, Guus A. de Waard, Lara S. F. Konijnenberg,

PLoS ONE

2016

56

Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospitalised COVID-19 patients

Justin de Brabander, Erik Duijvelaar, Job R. Schippers,

European Respiratory Journal

2022

51

Page 1